United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
568.43
+2.56 (0.45%)
May 22, 2026, 4:00 PM EDT - Market closed
United Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $707 → $701 | Buy | Maintains | $707 → $701 | +23.32% | May 7, 2026 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $575 → $738 | Hold → Buy | Upgrades | $575 → $738 | +29.83% | May 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $471 → $519 | Hold | Maintains | $471 → $519 | -8.70% | Apr 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $600 → $660 | Strong Buy | Maintains | $600 → $660 | +16.11% | Mar 31, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $486 → $575 | Hold | Maintains | $486 → $575 | +1.16% | Mar 31, 2026 |
| B of A Securities | B of A Securities | Hold Maintains $569 → $626 | Hold | Maintains | $569 → $626 | +10.13% | Mar 31, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $575 → $660 | Strong Buy | Maintains | $575 → $660 | +16.11% | Mar 30, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $466 → $486 | Hold | Maintains | $466 → $486 | -14.50% | Mar 23, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.